BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2855698)

  • 1. Growth control in mouse Y-1 adrenocortical tumor cells: role of c-Ki-ras amplification and effects of ACTH.
    Kimura E; Armelin HA
    Arch Biol Med Exp; 1988 Dec; 21(3-4):435-41. PubMed ID: 2855698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proto-oncogene c-Ki-ras amplification and overexpression in the malignancy of Y-1 adrenocortical tumor cells.
    Kimura E; Armelin HA
    Braz J Med Biol Res; 1988; 21(2):189-201. PubMed ID: 3060206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester mimics ACTH action in corticoadrenal cells stimulating steroidogenesis, blocking cell cycle, changing cell shape, and inducing c-fos proto-oncogene expression.
    Kimura E; Armelin HA
    J Biol Chem; 1990 Feb; 265(6):3518-21. PubMed ID: 2154481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.
    Schwab M; Alitalo K; Varmus HE; Bishop JM; George D
    Nature; 1983 Jun 9-15; 303(5917):497-501. PubMed ID: 6304530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
    Radinsky R; Kraemer PM; Raines MA; Kung HJ; Culp LA
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5143-7. PubMed ID: 3474646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Ki-ras oncogene amplification and FGF2 signaling pathways in the mouse Y1 adrenocortical cell line.
    Forti FL; Costa ET; Rocha KM; Moraes MS; Armelin HA
    An Acad Bras Cienc; 2006 Jun; 78(2):231-9. PubMed ID: 16710563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified DNA in Y1 mouse adrenal tumor cells: isolation of cDNAs complementary to an amplified c-Ki-ras gene and localization of homologous sequences to mouse chromosome 6.
    George DL; Scott AF; de Martinville B; Francke U
    Nucleic Acids Res; 1984 Mar; 12(6):2731-43. PubMed ID: 6546797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.
    McMahon G; Hanson L; Lee JJ; Wogan GN
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9418-22. PubMed ID: 3099282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line.
    Costa ET; Forti FL; Rocha KM; Moraes MS; Armelin HA
    Endocr Res; 2004 Nov; 30(4):503-9. PubMed ID: 15666780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH promotion of p27(Kip1) induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation.
    Forti FL; Schwindt TT; Moraes MS; Eichler CB; Armelin HA
    Biochemistry; 2002 Aug; 41(31):10133-40. PubMed ID: 12146978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
    Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
    Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH inhibits A Ras-dependent anti-apoptotic and mitogenic pathway in mouse Y1 adrenocortical cells.
    Forti FL; Armelin HA
    Endocr Res; 2000 Nov; 26(4):911-4. PubMed ID: 11196470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro growth properties and PCR ras gene analysis of a murine embryonal carcinoma cell line harboring an amplified c-Ki-ras gene.
    Vilette D; d'Auriol L; Galibert F; Peries J; Emanoil-Ravier R
    Biol Cell; 1989; 65(3):215-9. PubMed ID: 2665885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.
    Nardeux PC; Daya-Grosjean L; Landin RM; Andéol Y; Suàrez HG
    Biochem Biophys Res Commun; 1987 Jul; 146(2):395-402. PubMed ID: 3476115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of c-fos, c-jun and jun-B messenger ribonucleic acids by angiotensin-II and corticotropin in ovine and bovine adrenocortical cells.
    Viard I; Hall SH; Jaillard C; Berthelon MC; Saez JM
    Endocrinology; 1992 Mar; 130(3):1193-200. PubMed ID: 1311231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
    Radinsky R; Culp LA
    Int J Cancer; 1991 Apr; 48(1):148-59. PubMed ID: 2019453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.